Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone furoate nasal spray in allergic rhinitis
CTR20190822Phase 3Completed
- Sponsor
- Sichuan Otsuka Pharmaceutical
- Start
- May 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mometasone in allergic rhinitis (AR), seasonal allergic rhinitis (SAR), perennial rhinitis, sponsored by Sichuan Otsuka Pharmaceutical. Started May 2019; status: completed.
02
Drugs
mometasone
03
Conditions
allergic rhinitis (AR)seasonal allergic rhinitis (SAR)perennial rhinitis
Beyond the preview
Go deeper on CTR20190822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190822.